Possibilities and limitations of thromboelastometry/thromboelastography

Hamostaseologie

Volumn 26, Issue 3 SUPPL.1, 2006, Pages

  Lang, Thomas ^a,b   von Depka, M ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Werlhof Institut   (Germany)

Author keywords

ROTEM; TEG; Thrombelastography; Thrombelastometry

Indexed keywords

EID: 67651044054     PISSN: 07209355     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1617078     Document Type: Article

References (56)

1. Spahn DR. Strategies for transfusion therapy. Best Pract Res Clin Anaesthesiol 2004; 18: 661-73.
2. Bux J. Transfusion-related acute lung injury (TRALI): a serious adverse event of blood transfusion. Vox Sang 2005; 89: 1-10.
3. Goodnough LT. Risks of blood transfusion. Anesthesiol Clin North America 2005; 23: 241-252.
4. Stanworth SJ, Brunskill SJ, Hyde CJ et al. Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials. Br J Haematol 2004; 126: 139-152.
5. 9/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia. Blood 1998; 91: 3601-3606.
6. Koscielny J, Ziemer S, Radtke H et al. A practical concept for preoperative identification of patients with impaired primary hemostasis. Clin Appl Thromb Hemost 2004; 10: 195-204.
7. Oldenburg J, Ananyeva NM, Saenko EL. Molecular basis of haemophilia A. Haemophilia 2004; 10 (Suppl 4): 133-139.
8. Michiels JJ, Gadisseur A, Budde U et al. Characterization, classification, and treatment of von Willebrand diseases: a critical appraisal of the literature and personal experiences. Sem Thromb Hemost 2005; 31: 577-601.
9. Mannucci PM. Management of von Willebrand disease in developing countries. Sem Thromb Hemost 2005; 31: 602-609.
10. Petrini P. Treatment strategies in children with hemophilia. Paediatr Drugs 2002; 4: 427-437.
11. Boldt J, Papsdorf M, Rothe A et al. Changes of the hemostatic network in critically ill patients - Is there a difference between sepsis, trauma, and neurosurgery patients? Crit Care Med 2000; 28: 445-450.
12. Ozier Y, Steib A, Ickx B et al. Haemostatic disorders during liver transplantation. Eur J Anaesthesiol 2001; 18: 208-18.
13. Raja SG, Dreyfus GD. Impact of off-pump coronary artery bypass surgery on postoperative bleeding: current best available evidence. J Cardiol Surg 2006; 21: 35-41.
14. Kestin AS, Valeri CR, Khuri SF et al. The platelet function defect of cardiopulmonary bypass. Blood 1993; 82: 107-117.
15. Hoffman M, Monroe DM. A cell-based model of haemostasis. Thromb Haemost 2001; 85: 958-65.
16. Hassouna HI. Laboratory evaluation of hemostatic disorders. Hematol Oncol Clin North Am 1993; 7: 1161-1249.
17. Miller BE, Mochizuki T, Levy JH et al. Predicting and treating coagulopathies after cardiopulmonary bypass in children. Anesth Analg 1997; 85: 1196-1202.
18. Hartert H. Blutgerinnungsstudien mit der Thrombelastographie, einem neuen Untersuchungsverfahren. Klin Wochenschrift 1948; 26: 577-583.
19. Chandler WL. The thromboelastography and the thromboelastograph technique. Sem Thromb Hemost 1995; 21 (Suppl 4): 1-6.
20. Shore-Lesserson L, Manspeizer HE, DePerio M et al. Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg 1999; 88: 312-319.
21. Spiess BD, Gillies BS, Chandler W et al. Changes in transfusion therapy and reexploration rate after institution of a blood management program in cardiac surgical patients. J Cardiothorac Vasc Anesth 1995; 9: 168-173.
22. Spiess BD. Thromboelastography and cardiopulmonary bypass. Sem Thromb Hemost 1995; 21 (Suppl 4): 27-33.
23. Calatzis A, Fritsche P, Calatzis A et al. A comparison of the technical principle of the RoTEG coagulation analyser and conventional thrombelastographic systems. Ann Hematol 1996; 76 (Suppl): P90.
24. Calatzis A, Fritsche P, Kling M et al. A new technique for fast and specific intraoperative coagulation monitoring. Eur Surg Res 1996; 28 (Suppl I): 47-48.
25. Calatzis A, Calatzis A, Fritsche P et al. An analysis of the correlation of the RoTEG coagulation analysser and the Hellige thrombelastograph D. Ann Hematol 1996; 72 (Supp I): P87.
26. Mallett SV, Cox DJ. Thrombelastography. Br J Anaesth 1992; 69: 307-313.
27. Bowbrick VA, Mikhailidis DP, Stansby G. The use of citrated whole blood in thromboelastography. Anesth Analg 2000; 90: 1086-1088.
28. Camenzind V, Bombeli T, Seifert B et al. Citrate storage affects thrombelastograph analysis. Anesthesiology 2000; 92: 1242-1249.
29. Koster A, Kukucka M, Fischer T et al. Evaluation of post-cardiopulmonary bypass coagulation disorders by differential diagnosis with a multichannel modified thromboelastogram: a pilot investigation. J Extra Corpor Technol 2001; 33: 153-158.
30. Lang T, Toller W, Gutl M et al. Different effects of abciximab and cytochalasin D on clot strength in thrombelastography. J Thromb Haemost 2004; 2: 147-153.
31. Lang T, Bauters A, Braun SL et al. Multi-centre investigation on reference ranges for ROTEM thromboelastometry. Blood Coagul Fibrinol 2005; 16: 301-310.
32. Chuang J, Sadler MA, Witt DM. Impact of evacuated collection tube fill volume and mixing on routine coagulation testing using 2.5-ml (Pediatric) tubes. Chest 2004; 126: 1262-1266.
33. Nielsen VG, Geary BT, Baird MS. Evaluation of the contribution of platelets to clot strength by thromboelastography in rabbits: the role of tissue factor and cytochalasin D. Anesth Analg 2000; 91: 35-39.
34. Abramson DC, Abouleish EI, Pivalizza EG et al. Heparinase-guided thrombelastography in an anticoagulated patient. Br J Anaesth 1996; 77: 556-558.
35. Spiess BD, Wall MH, Gillies BS et al. A comparison of thromboelastography with heparinase or protamine sulfate added in vitro during heparinized cardiopulmonary bypass. Thromb Haemost 1997; 78: 820-826.
36. Mittermayr M, Margreiter J, Velik-Salchner C et al. Effects of protamine and heparin can be detected and easily differentiated by modified thrombelastography (Rotem): an in vitro study. Br J Anaesth 2005; 95: 310-316.
37. Mann KG, Butenas S, Brummel K. The dynamics of thrombin formation. Arterioscler Thromb Vas Biol 2003; 23: 17-25.
38. Phillips DR, Charo IF, Parise LV et al. The platelet membrane glycoprotein IIb-IIIa complex. Blood 1988; 71: 831-843.
39. Siebenlist KR, Meh DA, Mosesson MW. Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin. Thromb Haemost 2001; 86: 1221-1228.
40. Sorensen B, Johansen P, Christiansen K et al. Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation. J Thromb Haemost 2003; 1: 551-558.
41. Sorensen B, Ingerslev J. Whole blood clot formation phenotypes in hemophilia A and rare coagulation disorders. Patterns of response to recombinant factor VIIa. J Thromb Haemost 2004; 2: 102-110.
42. Sorensen B, Ingerslev J. Thromboelastography and recombinant factor VIIa-hemophilia and beyond. Sem Hematol 2004; 41(1 Suppl 1): 140-144.
43. Mahla E, Lang T, Vicenzi MN et al. Thromboelastography for monitoring prolonged hypercoagulability after major abdominal surgery. Anesth. Analg 2001; 92: 572-577.
44. Kettner SC, Panzer OP, Kozek SA et al. Use of abciximab-modified thrombelastography in patients undergoing cardiac surgery. Anesth Analg 1999; 89: 580-584.
45. Caprini JA, Arcelus JI, Goldshteyn S et al. Thromboelastography: measuring statistical probabilities. Sem Thromb Hemost 1995; 21 (Suppl 4): 14-20.
46. Luddington RJ. Thrombelastography/thromboelastometry. Clin Lab Haematol 2005; 27: 81-90.
47. Salooja N, Perry DJ. Thrombelastography. Blood Coagul Fibrinol 2001; 12: 327-337.
48. Samama CM. Thromboelastography: the next step. Anesth Analg 2001; 92: 563-564.
49. Goh KY, Tsoi WC, Feng CS et al. Haemostatic changes during surgery for primary brain tumours. J Neurol Neurosurg Psychiatry 1997; 63: 334-338.
50. Steer PL. Anaesthetic management of a parturient with thrombocytopenia using thrombelastography and sonoclot analysis. Can J Anaesth 1993; 40: 84-85.
51. Viana JS, Pereira MG, Lozano L et al. Thrombelastographic evidence of hyperfibrinolysis during liver transplantation for familial amyloidotic polyneuropathy ATTR Met 30. Transplant Proc 2000; 32: 2645-2646.
52. Whitta RK, Cox DJ, Mallett SV. Thrombelastography reveals two causes of haemorrhage in HELLP syndrome. Br J Anaesth 1995; 74: 464-468.
53. Ni H, Denis CV, Subbarao S et al. Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen. J Clin Invest 2000; 106: 385-392.
54. Greilich PE, Alving BM, O'Neill KL et al. A modified thromboelastographic method for monitoring C7E3 Fab in heparinized patients. Anesth Analg 1997; 84: 31-38.
55. Mousa SA, Khurana S, Forsythe MS. Comparative in vitro efficacy of different platelet glycoprotein IIb/IIIa antagonists on platelet-mediated clot strength induced by tissue factor with use of thromboelastography: differentiation among glycoprotein IIb/IIIa antagonists. Arterioscler Thromb Vasc Biol 2000; 20: 1162-1167.
56. Mousa SA, Forsythe MS. Comparison of the effect of different platelet GPIIb/IIa antagonists on the dynamics of platelet/fibrin-mediated clot strength induced using thromboelastography. Thromb Res 2001; 104: 49-56.